Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Benefits of Early Referral to Pediatric Palliative Care for a Child With a Rare Disease.

Vadeboncoeur C, McHardy M.

Pediatrics. 2018 Jun;141(6). pii: e20173417. doi: 10.1542/peds.2017-3417. Epub 2018 May 2. No abstract available.

2.

Predictors of Specialized Pediatric Palliative Care Involvement and Impact on Patterns of End-of-Life Care in Children With Cancer.

Widger K, Sutradhar R, Rapoport A, Vadeboncoeur C, Zelcer S, Kassam A, Nelson K, Liu Y, Wolfe J, Earle CC, Pole JD, Gupta S.

J Clin Oncol. 2018 Mar 10;36(8):801-807. doi: 10.1200/JCO.2017.75.6312. Epub 2018 Jan 22.

PMID:
29356606
3.

The Validity of Using Health Administrative Data To Identify the Involvement of Specialized Pediatric Palliative Care Teams in Children with Cancer in Ontario, Canada.

Widger K, Vadeboncoeur C, Zelcer S, Liu Y, Kassam A, Sutradhar R, Rapoport A, Nelson K, Wolfe J, Earle C, Pole JD, Gupta S.

J Palliat Med. 2017 Nov;20(11):1210-1216. doi: 10.1089/jpm.2017.0028. Epub 2017 Jun 8.

PMID:
28595025
4.

Challenges of research recruitment in a university setting in England.

Vadeboncoeur C, Foster C, Townsend N.

Health Promot Int. 2018 Oct 1;33(5):878-886. doi: 10.1093/heapro/dax025.

5.

Pediatric palliative care in Canada in 2012: a cross-sectional descriptive study.

Widger K, Davies D, Rapoport A, Vadeboncoeur C, Liben S, Sarpal A, Stenekes S, Cyr C, Daoust L, Grégoire MC, Robertson M, Hodgson-Viden H, Laflamme J, Siden H.

CMAJ Open. 2016 Oct 11;4(4):E562-E568. doi: 10.9778/cmajo.20160054. eCollection 2016 Oct-Dec.

6.

Erratum to: Freshman 15 in England: a longitudinal evaluation of first year university student's weight change.

Vadeboncoeur C, Foster C, Townsend N.

BMC Obes. 2016 Dec 9;3:53. eCollection 2016.

7.

Freshman 15 in England: a longitudinal evaluation of first year university student's weight change.

Vadeboncoeur C, Foster C, Townsend N.

BMC Obes. 2016 Nov 3;3:45. eCollection 2016. Erratum in: BMC Obes. 2016 Dec 9;3:53.

8.

A meta-analysis of weight gain in first year university students: is freshman 15 a myth?

Vadeboncoeur C, Townsend N, Foster C.

BMC Obes. 2015 May 28;2:22. doi: 10.1186/s40608-015-0051-7. eCollection 2015.

9.

Health-related quality of life and tuberculosis: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Health Qual Life Outcomes. 2015 May 27;13:65. doi: 10.1186/s12955-015-0250-4.

10.

Introducing a lexicon of terms for paediatric palliative care.

Spicer S, Macdonald ME, Davies D, Vadeboncoeur C, Siden H.

Paediatr Child Health. 2015 Apr;20(3):155-6. No abstract available. Erratum in: Paediatr Child Health. 2015 Nov-Dec;20(8):466-7.

11.

Case 2: A 10-year-old boy with leg pain and swelling.

Doherty M, Wheaton L, Vadeboncoeur C.

Paediatr Child Health. 2015 Apr;20(3):149-51. No abstract available.

12.

The use of natural health products by paediatric patients in respite care.

Beringer A, Vaillancourt R, Villarreal G, Vadeboncoeur C.

Paediatr Child Health. 2015 Jan-Feb;20(1):23-9.

13.

The impact of tuberculosis on health utility: a longitudinal cohort study.

Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjée B, Wynne A, Schwartzman K.

Qual Life Res. 2015 Jun;24(6):1337-49. doi: 10.1007/s11136-014-0858-6. Epub 2014 Nov 13.

PMID:
25391490
14.

Use of methadone for opioid weaning in children: prescribing practices and trends.

Giby K, Vaillancourt R, Varughese N, Vadeboncoeur C, Pouliot A.

Can J Hosp Pharm. 2014 Mar;67(2):149-56. No abstract available.

15.

Nutritional differences in neurologically impaired children.

Riley A, Vadeboncoeur C.

Paediatr Child Health. 2012 Nov;17(9):e98-e101.

16.

Effects of hypoxia-induced gill remodelling on the innervation and distribution of ionocytes in the gill of goldfish, Carassius auratus.

Tzaneva V, Vadeboncoeur C, Ting J, Perry SF.

J Comp Neurol. 2014 Jan 1;522(1):118-30. doi: 10.1002/cne.23392.

17.

A comparative cost-minimization analysis of providing paediatric palliative respite care before and after the opening of services at a paediatric hospice.

Pascuet E, Cowin L, Vaillancourt R, Splinter W, Vadeboncoeur C, Dumond LG, Ni A, Rattray M.

Healthc Manage Forum. 2010 Summer;23(2):63-6.

PMID:
21739841
18.

Palliative care consultation in pediatric oncology.

Johnston DL, Vadeboncoeur C.

Support Care Cancer. 2012 Apr;20(4):799-803. doi: 10.1007/s00520-011-1152-6. Epub 2011 Apr 9.

PMID:
21479523
19.

Successful treatment of a seizure disorder with chronic high-dose chloral hydrate: a pediatric case report.

Vaillancourt R, Collins M, Vadeboncoeur C, Jacob P, Graham N, Foster D, Splinter W.

J Palliat Care. 2010 Winter;26(4):311-3. No abstract available.

PMID:
21268525
20.

Kinetic studies of HPr, HPr(H15D), HPr(H15E), and HPr(His approximately P) phosphorylation by the Streptococcus salivarius HPr(Ser) kinase/phosphorylase.

Casabon I, Couture M, Vaillancourt K, Vadeboncoeur C.

Biochemistry. 2009 Nov 17;48(45):10765-74. doi: 10.1021/bi901512b.

PMID:
19824696
21.

Treatment of medication intolerance with lactase in a complex palliative care patient.

Vaillancourt R, Siddiqui R, Vadeboncoeur C, Rattray M, Larivière D.

J Palliat Care. 2009 Summer;25(2):142-4. No abstract available.

PMID:
19678468
22.

A paediatric palliative care programme in development: trends in referral and location of death.

Vadeboncoeur CM, Splinter WM, Rattray M, Johnston DL, Coulombe L.

Arch Dis Child. 2010 Sep;95(9):686-9. doi: 10.1136/adc.2008.153494. Epub 2009 Jul 7.

PMID:
19586925
23.

Fat-free yogurt made using a galactose-positive exopolysaccharide-producing recombinant strain of Streptococcus thermophilus.

Robitaille G, Tremblay A, Moineau S, St-Gelais D, Vadeboncoeur C, Britten M.

J Dairy Sci. 2009 Feb;92(2):477-82. doi: 10.3168/jds.2008-1312.

24.

Streptococci and lactococci synthesize large amounts of HPr(Ser-P)(His~P).

Roy DJ, Casabon I, Vaillancourt K, Huot JL, Vadeboncoeur C.

Can J Microbiol. 2008 Nov;54(11):941-9. doi: 10.1139/w08-085.

PMID:
18997850
25.

Role of galK and galM in galactose metabolism by Streptococcus thermophilus.

Vaillancourt K, Bédard N, Bart C, Tessier M, Robitaille G, Turgeon N, Frenette M, Moineau S, Vadeboncoeur C.

Appl Environ Microbiol. 2008 Feb;74(4):1264-7. Epub 2007 Dec 7.

26.

Galactose metabolism and capsule formation in a recombinant strain of Streptococcus thermophilus with a galactose-fermenting phenotype.

Robitaille G, Moineau S, St-Gelais D, Vadeboncoeur C, Britten M.

J Dairy Sci. 2007 Sep;90(9):4051-7.

27.

Detection and quantification of capsular exopolysaccharides from Streptococcus thermophilus using lectin probes.

Robitaille G, Moineau S, St-Gelais D, Vadeboncoeur C, Britten M.

J Dairy Sci. 2006 Nov;89(11):4156-62.

28.

Synthesis of HPr(Ser-P)(His-P) by enzyme I of the phosphoenolpyruvate: sugar phosphotransferase system of Streptococcus salivarius.

Casabon I, Couture M, Vaillancourt K, Vadeboncoeur C.

Biochemistry. 2006 May 30;45(21):6692-702.

PMID:
16716080
29.

Use of an alpha-galactosidase gene as a food-grade selection marker for Streptococcus thermophilus.

Labrie S, Bart C, Vadeboncoeur C, Moineau S.

J Dairy Sci. 2005 Jul;88(7):2341-7.

30.

Relapse of Wilms' tumor 13 years after original diagnosis.

Gibson PJ, Vadeboncoeur CM, Johnston DL.

J Pediatr Hematol Oncol. 2005 May;27(5):293-4. No abstract available.

PMID:
15891569
31.
32.

Characterization of the cro-ori region of the Streptococcus thermophilus virulent bacteriophage DT1.

Lamothe G, Lévesque C, Bissonnette F, Cochu A, Vadeboncoeur C, Frenette M, Duplessis M, Tremblay D, Moineau S.

Appl Environ Microbiol. 2005 Mar;71(3):1237-46.

33.

The relevance of genetic analysis to dairy bacteria: building upon our heritage.

Vadeboncoeur C, Moineau S.

Microb Cell Fact. 2004 Dec 10;3(1):15.

34.

Characterization of a galactokinase-positive recombinant strain of Streptococcus thermophilus.

Vaillancourt K, LeMay JD, Lamoureux M, Frenette M, Moineau S, Vadeboncoeur C.

Appl Environ Microbiol. 2004 Aug;70(8):4596-603.

35.
36.

Purification and characterization of the Streptococcus salivarius methionine aminopeptidase (MetAP).

Boufous el H, Vadeboncoeur C.

Biochimie. 2003 Oct;85(10):993-7.

PMID:
14644554
37.

Phosphorylation of Streptococcus salivarius lactose permease (LacS) by HPr(His ~ P) and HPr(Ser-P)(His ~ P) and effects on growth.

Lessard C, Cochu A, Lemay JD, Roy D, Vaillancourt K, Frenette M, Moineau S, Vadeboncoeur C.

J Bacteriol. 2003 Dec;185(23):6764-72.

38.
39.

The HPr(Ser) kinase of Streptococcus salivarius: a hexameric bifunctional enzyme controlled by glycolytic intermediates and inorganic phosphate.

Frey N, Nessler S, Fieulaine S, Vaillancourt K, Frenette M, Vadeboncoeur C.

FEMS Microbiol Lett. 2003 Jul 15;224(1):67-72.

40.

Characterization of genes involved in the metabolism of alpha-galactosides by Lactococcus raffinolactis.

Boucher I, Vadeboncoeur C, Moineau S.

Appl Environ Microbiol. 2003 Jul;69(7):4049-56.

41.

Novel food-grade plasmid vector based on melibiose fermentation for the genetic engineering of Lactococcus lactis.

Boucher I, Parrot M, Gaudreau H, Champagne CP, Vadeboncoeur C, Moineau S.

Appl Environ Microbiol. 2002 Dec;68(12):6152-61.

44.
45.

Regulation of the pts operon in low G+C Gram-positive bacteria.

Vadeboncoeur C, Frenette M, Lortie LA.

J Mol Microbiol Biotechnol. 2000 Oct;2(4):483-90. Review.

PMID:
11075921
46.

Enzyme I and HPr from Lactobacillus casei: their role in sugar transport, carbon catabolite repression and inducer exclusion.

Viana R, Monedero V, Dossonnet V, Vadeboncoeur C, Pérez-Martínez G, Deutscher J.

Mol Microbiol. 2000 May;36(3):570-84.

47.
48.

Phenotypic consequences resulting from a methionine-to-valine substitution at position 48 in the HPr protein of Streptococcus salivarius.

Plamondon P, Brochu D, Thomas S, Fradette J, Gauthier L, Vaillancourt K, Buckley N, Frenette M, Vadeboncoeur C.

J Bacteriol. 1999 Nov;181(22):6914-21.

49.

An effective strategy, applicable to Streptococcus salivarius and related bacteria, to enhance or confer electroporation competence.

Buckley ND, Vadeboncoeur C, LeBlanc DJ, Lee LN, Frenette M.

Appl Environ Microbiol. 1999 Sep;65(9):3800-4. Erratum in: Appl Environ Microbiol 1999 Dec;65(12):5642.

50.

Supplemental Content

Loading ...
Support Center